Michael Ulz
Stock Analyst at Morgan Stanley
(1.34)
# 3,688
Out of 5,090 analysts
607
Total ratings
38.8%
Success rate
-0.2%
Average return
Main Sectors:
Stocks Rated by Michael Ulz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Rated: Hold | $300 → $240 | $165.00 | +45.45% | 51 | Oct 30, 2026 | |
| KYMR Kymera Therapeutics | Rated: Buy | $146 → $150 | $126.63 | +18.46% | 2 | Oct 30, 2026 | |
| VKTX Viking Therapeutics | Rated: Buy | $95 | $27.28 | +248.24% | 28 | Oct 29, 2026 | |
| AGMB AgomAb Therapeutics NV | Rated: Buy | $28 | $7.49 | +273.83% | 1 | Oct 26, 2026 | |
| AARD Aardvark Therapeutics | Reiterated: Sell | $3 | $1.36 | +120.59% | 10 | Oct 22, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $104 | $43.52 | +138.97% | 41 | Oct 21, 2026 | |
| ADRX ADARx Pharmaceuticals | Initiated Coverage: Buy | $32 | $17.00 | +88.24% | 1 | Oct 20, 2026 | |
| GUTS Fractyl Health | Reiterated: Hold | $24 → $4 | $0.9765 | +309.63% | 21 | Oct 19, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $137 → $152 | $85.00 | +78.82% | 27 | Oct 13, 2026 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Hold | $5 | $2.44 | +104.92% | 20 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $36 | $16.69 | +115.70% | 26 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $59.90 | +100.33% | 28 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $92.57 | +62.04% | 22 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $13 | $1.51 | +760.93% | 22 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 | $5.67 | +482.01% | 24 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $32 | $19.75 | +62.03% | 34 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 → $20 | $5.87 | +240.72% | 16 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $5 | $1.96 | +155.10% | 13 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $25 | $18.62 | +34.26% | 31 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $27 → $25 | $11.30 | +121.24% | 24 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.3674 | +444.37% | 15 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.39 → $0.36 | $0.0001 | +359,900.00% | 13 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $8.03 | n/a | 8 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $2.08 | n/a | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $5 | $10.23 | n/a | 2 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.5 | $2.03 | n/a | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.662 | n/a | 18 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1651 | n/a | 3 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 | $32.28 | n/a | 12 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $60 → $23 | $8.48 | n/a | 2 | May 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $4.13 | n/a | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $3 | $19.78 | n/a | 2 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $58.51 | n/a | 15 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8301 | n/a | 12 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $31.96 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $27.55 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $16.10 | n/a | 13 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 | $892.87 | n/a | 6 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $69 → $60 | $11.03 | n/a | 2 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $26.80 | n/a | 3 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.98 | n/a | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $13.65 | n/a | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $9.24 | n/a | 1 | Aug 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $8 | $0.000001 | n/a | 4 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $40 | $2.48 | n/a | 5 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $4.04 | n/a | 1 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $170.68 | n/a | 1 | May 18, 2010 |
Alnylam Pharmaceuticals
Oct 30, 2026
Rated: Hold
Price Target: $300 → $240
Current: $165.00
Upside: +45.45%
Kymera Therapeutics
Oct 30, 2026
Rated: Buy
Price Target: $146 → $150
Current: $126.63
Upside: +18.46%
Viking Therapeutics
Oct 29, 2026
Rated: Buy
Price Target: $95
Current: $27.28
Upside: +248.24%
AgomAb Therapeutics NV
Oct 26, 2026
Rated: Buy
Price Target: $28
Current: $7.49
Upside: +273.83%
Aardvark Therapeutics
Oct 22, 2026
Reiterated: Sell
Price Target: $3
Current: $1.36
Upside: +120.59%
Ionis Pharmaceuticals
Oct 21, 2026
Reiterated: Buy
Price Target: $104
Current: $43.52
Upside: +138.97%
ADARx Pharmaceuticals
Oct 20, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $17.00
Upside: +88.24%
Fractyl Health
Oct 19, 2026
Reiterated: Hold
Price Target: $24 → $4
Current: $0.9765
Upside: +309.63%
Mirum Pharmaceuticals
Oct 13, 2026
Reiterated: Buy
Price Target: $137 → $152
Current: $85.00
Upside: +78.82%
Rocket Pharmaceuticals
Oct 7, 2026
Reiterated: Hold
Price Target: $5
Current: $2.44
Upside: +104.92%
Sep 9, 2026
Reiterated: Buy
Price Target: $45 → $36
Current: $16.69
Upside: +115.70%
Aug 31, 2026
Reiterated: Buy
Price Target: $120
Current: $59.90
Upside: +100.33%
Aug 24, 2026
Reiterated: Buy
Price Target: $150
Current: $92.57
Upside: +62.04%
Aug 17, 2026
Rated: Buy
Price Target: $13
Current: $1.51
Upside: +760.93%
Aug 12, 2026
Rated: Buy
Price Target: $33
Current: $5.67
Upside: +482.01%
Aug 11, 2026
Rated: Buy
Price Target: $25 → $32
Current: $19.75
Upside: +62.03%
Aug 7, 2026
Reiterated: Hold
Price Target: $23 → $20
Current: $5.87
Upside: +240.72%
Aug 7, 2026
Reiterated: Hold
Price Target: $4 → $5
Current: $1.96
Upside: +155.10%
Aug 6, 2026
Rated: Hold
Price Target: $25
Current: $18.62
Upside: +34.26%
Aug 6, 2026
Rated: Buy
Price Target: $27 → $25
Current: $11.30
Upside: +121.24%
Jun 3, 2026
Reiterated: Buy
Price Target: $2
Current: $0.3674
Upside: +444.37%
Jan 8, 2026
Downgraded: Sell
Price Target: $0.39 → $0.36
Current: $0.0001
Upside: +359,900.00%
Mar 11, 2025
Reiterated: Buy
Price Target: $5
Current: $8.03
Upside: n/a
Mar 6, 2025
Reiterated: Hold
Price Target: $5
Current: $2.08
Upside: n/a
Feb 11, 2025
Downgraded: Hold
Price Target: $20 → $5
Current: $10.23
Upside: n/a
Aug 13, 2024
Reiterated: Sell
Price Target: $0.5
Current: $2.03
Upside: n/a
Dec 15, 2023
Rated: Hold
Price Target: n/a
Current: $0.662
Upside: n/a
Dec 15, 2023
Rated: Hold
Price Target: n/a
Current: $0.1651
Upside: n/a
Aug 22, 2023
Reiterated: Hold
Price Target: $40
Current: $32.28
Upside: n/a
May 22, 2023
Rated: Buy
Price Target: $60 → $23
Current: $8.48
Upside: n/a
Jan 27, 2023
Downgraded: Hold
Price Target: $3
Current: $4.13
Upside: n/a
Jan 5, 2022
Reiterated: Hold
Price Target: $7 → $3
Current: $19.78
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $58.51
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $0.8301
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $31.96
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $27.55
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $16.10
Upside: n/a
Mar 4, 2021
Reiterated: Buy
Price Target: $340
Current: $892.87
Upside: n/a
Mar 1, 2021
Reiterated: Hold
Price Target: $69 → $60
Current: $11.03
Upside: n/a
Feb 16, 2021
Reiterated: Buy
Price Target: n/a
Current: $26.80
Upside: n/a
Jan 29, 2021
Reiterated: Buy
Price Target: $5
Current: $2.98
Upside: n/a
Jan 29, 2021
Reiterated: Buy
Price Target: $37
Current: $13.65
Upside: n/a
Aug 12, 2020
Initiated Coverage: Buy
Price Target: $45
Current: $9.24
Upside: n/a
Jul 30, 2020
Reiterated: Buy
Price Target: $15 → $8
Current: $0.000001
Upside: n/a
Mar 28, 2019
Reiterated: Hold
Price Target: $3 → $40
Current: $2.48
Upside: n/a
Oct 3, 2017
Rated: Buy
Price Target: n/a
Current: $4.04
Upside: n/a
May 18, 2010
Reiterated: Buy
Price Target: $28
Current: $170.68
Upside: n/a